Placenta Market Anticipated to Hit USD 1,404.87 million by 2034, Expanding at a CAGR of 8.9%

Placenta Market

According to Polaris Market Research analysis, the global placenta market was valued at USD 599.45 million in 2024 and is projected to reach USD 1,404.87 million by 2034, registering a compound annual growth rate (CAGR) of 8.9% from 2025-2034.

Market Explanation

The placenta has regenerative and anti-aging properties. The components are animal and plant placenta extract that comprises vitamins, peptides, growth factors, and antioxidants. These work together to increase the rate of restoration of skin cells, strengthening the skin and providing a youthful glow and brilliance. Several beauty trends, such as Korean and Japanese, have hugely revived placenta cream, serum, and masks, and they are now gaining traction among beauty enthusiasts.

Placenta cells comprise of abundance of nutrients and proteins. In nonsurgical hair repairing, donated placental stem cells are reaped and assorted with platelet-rich plasma to encourage contemporary hair growth. It also contains a distinct protein hormone known as human placental lactogen (hPL). hPL allocates structural constituents with growth hormones and assists in securing them with other growth hormones.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/placenta-market/request-for-sample

Market Growth Drivers

Growing Usage in Regenerative Medicines: Placenta is increasingly utilized in regenerative medicine and injury alleviating applications, especially in detrimental wounds, burns, and orthopaedic situations. Placental-procured biologics involving amniotic membrane commodities, placental stem cells, and extracellular matrix constituents have displayed outstanding efficiency in speeding tissue recuperation, decreasing swelling, and improving angiogenesis, supporting the placenta market expansion.

Rising Funding in Placental Procured Therapies: The market is experiencing rapid growth as the biopharmaceutical industry funds in placental procured therapies for progressive medical cure. With its abundant source of stem cells and bioactive molecules, the placenta is playing an important part in advancing next-generation biologics. One of the key shifts is the growing concentration on autoimmune illnesses, neurological illnesses, and oncology, where placental stem cell therapies display robust potential.

Competitive Landscape

The market is characterized by a complex mix of established players, emerging companies, and research organizations focused on placenta-related studies and innovations. The leading market participants are listed as follows:

• Albert David Limited
• Atlanta Placenta Encapsulation
• Japan Bio Products Co., Ltd.
• Japan Natural Laboratories Co., Ltd.
• MIMEDX Group, Inc.
• Mommy Made Encapsulation
• Nubloom LLC
• PURTIER Placenta
• Smith and Nephew
• The Placenta Company

Inquire more about this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/placenta-market/inquire-before-buying

Placenta Market Report Highlights

📚 Based on type, the porcine segment dominated the placenta market share in 2024 due to its versatility and availability of porcine placenta. Porcine (pig) placenta is emerging as a valuable resource in the market, owing to its rich composition of collagen, proteins, and bioactive peptides.
📚 The pharmaceuticals segment, by application, is estimated to register the highest CAGR during the forecast period. In the pharmaceutical segment, placental extracts have been explored for their therapeutic properties. The rich composition of bioactive molecules such as growth factors, cytokines, and extracellular vesicles makes placental extracts promising candidates for therapeutic applications.
📚 North America dominated the global placenta market revenue share in 2024 due to factors such as increasing demand for placenta-based cosmetics, health supplements, and pharmaceutical products.
📚 The market in Asia Pacific is expected to register the highest CAGR in the coming years owing to rising prevalence of rare diseases such as muscular dystrophy and growing demand for placenta-based supplements.

Regional Outlook

Regional augmentation policies in the placenta market are also important, with firms earmarking surfacing markets to benefit from the growing demand.
North America accounted for a significant market share in 2024, driven by growing demand for placenta-based cosmetics, health supplements, and pharmaceutical commodities. In North America, a surge in placenta demand is excessively propelled by escalating disposable income and growing consciousness of health and skincare advantages.

Asia Pacific is expected to register a significant CAGR during the forecast period, fuelled by the growing prevalance of chronic illnesses such as muscular dystrophy and the growing demand for placenta-based supplements.

Placenta Market, Regional Outlook (Revenue - USD Million, 2020-2034)
🔹 North America
» Type Outlook
» Porcine
» Equine
» Ovine
» Others
» Application Outlook
» Pharmaceuticals
» Cosmetics
» Supplements
» Others

🔹 Europe
» Type Outlook
» Porcine
» Equine
» Ovine
» Others
» Application Outlook
» Pharmaceuticals
» Cosmetics
» Supplements
» Others

Explore The Complete Report:
https://www.polarismarketresearch.com/industry-analysis/placenta-market

Segmental Division

Placenta Market, Type Outlook (Revenue - USD Million, 2020-2034)
• Porcine
• Equine
• Ovine
• Others

Placenta Market, Application Outlook (Revenue - USD Million, 2020-2034)
• Pharmaceuticals
• Cosmetics
• Supplements
• Others

More Trending Reports by Polaris Market Research:

Inspection Machines Market:
https://www.polarismarketresearch.com/industry-analysis/inspection-machines-market

Synthetic Biology Market:
https://www.polarismarketresearch.com/industry-analysis/synthetic-biology-market

Lateral Flow Assay Market:
https://www.polarismarketresearch.com/industry-analysis/lateral-flow-assay-market

Infection Control Market:
https://www.polarismarketresearch.com/industry-analysis/infection-control-market

Leading 20 Companies Innovating in the mHealth Market:
https://www.polarismarketresearch.com/blog/leading-20-companies-innovating-in-the-mhealth-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.